| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 44 |
| 1 | OMEPRAZOLE | 38 |
| 2 | OMEPRAZOLE MAGNESIUM | 38 |
| 3 | LANSOPRAZOLE | 27 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 21 |
| 5 | RABEPRAZOLE SODIUM | 18 |
| 6 | ASPIRIN | 16 |
| 7 | ASPIRIN 325 MG | 16 |
| 8 | ASPIRIN 81 MG | 16 |
| 9 | ESOMEPRAZOLE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMEPRAZOLE 20MG | 3 | 0.0026 |
| 1 | BUFFERED ASPIRIN | 3 | 0.0021 |
| 2 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 3 | SILODOSIN | 8 | 0.0020 |
| 4 | DEGARELIX | 7 | 0.0013 |
| 5 | GLUCAGON | 3 | 0.0007 |
| 6 | RABEPRAZOLE SODIUM | 18 | 0.0007 |
| 7 | CALCITRIOL CAPSULES 0.25 MCG | 11 | 0.0005 |
| 8 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 9 | CROMOLYN SODIUM | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 57 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 3 | Aldosterone Antagonist [EPC] | 15 |
| 4 | Vitamin D3 Analog [EPC] | 11 |
| 5 | alpha-Adrenergic Blocker [EPC] | 10 |
| 6 | Corticosteroid [EPC] | 9 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| 8 | Loop Diuretic [EPC] | 9 |
| 9 | Benzodiazepine [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 3 | 0.0007 |
| 1 | Vitamin D3 Analog [EPC] | 11 | 0.0005 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Proton Pump Inhibitor [EPC] | 57 | 0.0001 |
| 4 | Aldosterone Antagonist [EPC] | 15 | 0.0001 |
| 5 | Dietary Cholesterol Absorption Inhibitor [EPC] | 8 | 0.0001 |
| 6 | alpha-Adrenergic Blocker [EPC] | 10 | 0.0001 |
| 7 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 7 | 0.0001 |